The polymyxin resistance testing market size is projected to be worth USD 122.0 million in 2023. The market is likely to surpass USD 222.5 million by 2033 at a CAGR of 6.2% during the forecast period. The industry that develops, produces, and distributes tests and assays intended to identify and evaluate resistance to polymyxin antibiotics is referred to as the Polymyxin Resistance Testing Market.A class of antibiotics known as polymyxins is used to treat severe infections brought on by bacteria that are multidrug resistant, particularly Gram-negative bacteria.
Bacteria that have acquired genetic mutations or resistance genes that make them less vulnerable to or entirely resistant to the effects of polymyxin antibiotics develop polymyxin resistance. Testing for polymyxin resistance is performed to find these resistant bacteria and establish the best course of therapy.
Other Drivers Propelling the Demand for Polymyxin Resistance Testing include:
Challenges for Companies /Manufacturers in the Polymyxin Resistance Testing Market:
Opportunities in the Polymyxin Resistance Testing Industry:
Latest Trends in the Polymyxin Resistance Testing Market:
| Attributes | Details |
|---|---|
| Polymyxin Resistance Testing Market Size (2023) | USD 122.0 million |
| Polymyxin Resistance Testing Market Projected Size (2033) | USD 222.5 million |
| Value CAGR (2023 to 2033) | 6.2% |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
From 2017 to 2022, the global polymyxin resistance testing market experienced a CAGR of 6.0%, reaching a market size of USD 122.0 million in 2023.
From 2017 to 2022, As multidrug-resistant Gram-negative bacteria are becoming more common, polymyxin resistance has grown to be a serious issue in the field of antimicrobial resistance. The market's historical outlook shows that this issue has been acknowledged, and that there is a consequent need for efficient testing procedures to detect and control polymyxin resistance.
Future Forecast for Polymyxin Resistance Testing Industry:
Looking ahead, the global polymyxin resistance testing industry is expected to rise at a CAGR of 6.2% from 2023 to 2033 reaching valuation of USD 222.5 million by the end of 2033. The rise in polymyxin-resistant bacterial infections, such as carbapenem-resistant Enterobacteriaceae (CRE) and multidrug-resistant Gram-negative bacteria, is expected to drive the demand for polymyxin resistance testing. As antimicrobial resistance becomes a global health concern, the need for accurate and timely testing to guide
| Country | The United States |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 56.1 million |
| CAGR % 2023 to End of Forecast (2033) | 6.2% |
The polymyxin resistance testing industry in the United States is expected to reach a market size of USD 56.1 million by 2033, expanding at a CAGR of 6.2%. In order to reduce the risk of healthcare-associated infections (HAIs), infection control techniques have received a lot of attention in healthcare settings, including hospitals and long-term care facilities. Healthcare practitioners can implement effective infection control measures by using polymyxin resistance tests to identify patients who have been colonized or infected with polymyxin-resistant bacteria. Testing for polymyxin resistance is more popular due to rising infection control knowledge and emphasis.
| Country | The United Kingdom |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 7.4 million |
| CAGR % 2023 to End of Forecast (2033) | 4.8% |
The polymyxin resistance testing industry in the United Kingdom is expected to reach a market value of USD 7.4 million, expanding at a CAGR of 4.8% during the forecast period. The UK government has implemented various initiatives and policies to address the challenge of antibiotic resistance. These initiatives include the UK Five-Year Antimicrobial Resistance Strategy and the Antimicrobial Resistance (AMR) Action Plan. The government and regulatory bodies provide support and guidance for the development and implementation of accurate and reliable resistance testing methods, including polymyxin resistance testing. The supportive regulatory environment encourages market growth.
| Country | China |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 19.0 million |
| CAGR % 2023 to End of Forecast (2033) | 7.5% |
The polymyxin resistance testing industry in China is anticipated to reach a market size of USD 19.0 million, moving at a CAGR of 7.5% during the forecast period. China has been increasing its healthcare expenditure and focusing on the development of healthcare infrastructure. This includes the expansion and improvement of diagnostic facilities and laboratory capabilities. The investment in healthcare infrastructure supports the adoption of advanced testing methods, including polymyxin resistance testing, and contributes to market growth.
| Country | Japan |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 13.3 million |
| CAGR % 2023 to End of Forecast (2033) | 7.1% |
The polymyxin resistance testing industry in Japan is estimated to reach a market size of USD 13.3 million by 2033, thriving at a CAGR of 7.1%. Japan has a well-developed healthcare infrastructure, including sophisticated diagnostic facilities and laboratory capabilities. The availability of advanced technologies and equipment facilitates the adoption of cutting-edge diagnostic methods, including polymyxin resistance testing. The advanced healthcare infrastructure supports the growth of the market by enabling accurate and efficient testing.
| Country | South Korea |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 5.6 million |
| CAGR % 2023 to End of Forecast (2033) | 6.6% |
The polymyxin resistance testing industry in South Korea is expected to reach a market size of USD 5.6 million, expanding at a CAGR of 6.6% during the forecast period. Research and development activities in the field of polymyxin resistance testing are promoted in South Korea through cooperative efforts between research institutions, healthcare organizations, and industry participants.
Joint research projects seek to improve testing procedures, broaden the spectrum of observable resistance mechanisms, and increase data reporting and interpretation. The Polymyxin Resistance Testing Market in South Korea is expanding due to cooperative research and development initiatives.
The testing systems is expected to dominate the polymyxin resistance testing industry with a CAGR of 6.4% from 2023 to 2033. Testing systems are designed to detect the presence of specific resistance mechanisms or genes that confer resistance to polymyxin antibiotics. These systems employ various techniques, such as polymerase chain reaction (PCR), DNA sequencing, and phenotypic testing, to identify resistance in bacterial strains. Accurate and reliable detection of polymyxin resistance is essential for guiding appropriate treatment decisions and preventing the spread of resistant strains.
The Broth Microdilution (BMD) segments are expected to grow at significant rate due to its greater adoption as compared other testing methods within the polymyxin resistance testing industry with a CAGR of 7.0% from 2023 to 2033. Broth Microdilution (BMD) is a widely accepted and standardized method for testing bacterial susceptibility to antimicrobial agents, including polymyxins. It involves diluting antimicrobial agents in a liquid growth medium, inoculating bacterial strains, and measuring the minimum inhibitory concentration (MIC) of the drug required to inhibit bacterial growth. The standardized nature of BMD ensures consistent and reproducible results, making it a valuable tool for researchers, clinicians, and regulatory authorities.
The academic & research institutions segment is expected to dominate the polymyxin resistance testing industry with a CAGR of 7.0% from 2023 to 2033. Academic and research institutions play a vital role in the development and validation of testing methods for polymyxin resistance. They conduct extensive research to identify new resistance mechanisms, understand the genetic basis of resistance, and develop innovative testing approaches. This research contributes to the advancement of testing methods, enabling more accurate and reliable detection of polymyxin resistance.
The market for polymyxin resistance testing is highly competitive, with numerous businesses vying for supremacy. Important players must use cunning tactics in such a situation to stay ahead of the opposition.
Key Strategies Used by the Participants
To produce innovative goods that increase efficacy, dependability, and cost-effectiveness, businesses make significant investments in research and development. Product innovation enables companies to stand out from the competition while also meeting the shifting needs of their customers.
Key industry leaders frequently develop strategic partnerships and collaborations with other companies in order to harness their strengths and increase their market reach. Companies might also gain access to new technology and markets through such agreements.
The polymyxin resistance testing sector is expanding rapidly in emerging regions such as China and India. Key firms are enhancing their distribution networks and developing local manufacturing facilities to increase their presence in these areas.
Mergers and acquisitions are frequently used by key players in the polymyxin resistance testing business to consolidate their market position, extend their product range, and gain access to new markets.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
Key Developments in the Polymyxin Resistance Testing Market:
In 2023, the market is likely to generate USD 122 million revenue.
The market is poised to witness 6.2% CAGR through 2033.
The testing systems segment is poised to expand at 6.4% CAGR up till 2033.
The United States polymyxin resistance testing market could witness 6.2% CAGR until 2033.
Polymyxin resistance testing in China is poised to record a 7.5% CAGR through 2033.
Explore In-vitro Diagnostics Devices Insights
View Reports
Polymyxin Resistance Testing Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
